Engineering Fundamentals in Life Science

Session 182 - Disease Therapies and Diagnostics
The intersection of engineering and biology has facilitated many recent medical advances. This session seeks submissions that address engineering advancements towards the diagnosis and treatment of disease via the implementation of novel techniques, materials, or processes or the novel application of established techniques or materials. Areas of interest include, but are not limited to, innovations in drug design, drug targeting, high throughput screening, biosensors, biomaterials, genetic engineering, and proteomics.
Chair:Melissa A. Moss
CoChair:Adam T. Capitano
CoSponsor(s):Engineering Fundamentals in Life Science
 An Injectable Polymeric Device for Drug Delivery and Sensing
Karen Daniel, Grace Kim, Christophoros Vassiliou, Michael Cima, Robert Langer
 Application of Immunomagnetic Cell Enrichment in Combination with Rt- Pcr for the Detection of Rare Circulating Cancer Cells in Peripheral Blood and Bone Marrow from Patients with Head and Neck Squamous Cell Carcinoma (Hnscc)
Liying Yang, Xiaodong Tong, James, Campbell Lang, Maciej Zborowski, Jeffrey J. Chalmers
 Cd4+ T-Cell Epitope Identification Using Yeast Displaying Single Chain Class II Mhc Molecules as Artificial Apcs
Fei Wen, Huimin Zhao
 Detection of Active Amyloid-Beta Species Using a Quartz Crystal Microbalance
Joseph A. Kotarek, Melissa A. Moss
 Break
 Development of Novel Sialic Acid Containing Polymers for Use in Alzheimer's Disease
Theresa A. Good, Dhara Patel, Christopher Cowan
 Assessment of Islet Quality
Anna Pisania, Klearchos K. Papas, Susan Bonner-Weir, Gordon C. Weir, Clark K. Colton
 Metabolic Re-Engineering for Obesity Drug Target Identification: Flux Analysis and Gene Profiling of Forced Uncoupling Protein 1 Expression in 3t3-L1 Cells
Yaguang Si, Santosh Palani, Fatih Senocak, Arul Jayaraman, Kyongbum Lee

See more of Food, Pharmaceutical & Bioengineering Division